Category Archives: Top Market News

Maxim Group Keeps a Buy Rating on BioLife Solutions (BLFS)

In a report released yesterday, Jason McCarthy from Maxim Group maintained a Buy rating on BioLife Solutions (BLFS – Research Report), with a price target of $24. The company’s shares opened today at $18.40. McCarthy wrote: “On 5/9, BioLife reported

Maxim Group Keeps Their Buy Rating on Agile Therapeutics (AGRX)

Maxim Group analyst Jason McCarthy maintained a Buy rating on Agile Therapeutics (AGRX – Research Report) yesterday and set a price target of $3. The company’s shares opened today at $1.33. McCarthy observed: “Agile announced that the FDA has accepted

H.C. Wainwright Believes Iovance Biotherapeutics Inc (NASDAQ: IOVA) Won’t Stop Here

In a report released today, Joseph Pantginis from H.C. Wainwright reiterated a Buy rating on Iovance Biotherapeutics Inc (IOVA – Research Report), with a price target of $26. The company’s shares closed yesterday at $16.63, close to its 52-week high

Analysts Offer Insights on Healthcare Companies: PAVmed Inc (NASDAQ: PAVM) and Aurinia Pharmaceuticals (NASDAQ: AUPH)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on PAVmed Inc (PAVM – Research Report) and Aurinia Pharmaceuticals (AUPH – Research Report) with bullish sentiments. PAVmed Inc (PAVM) In a report

H.C. Wainwright Remains a Buy on Magic Software Enterprises Ltd (MGIC)

H.C. Wainwright analyst Kevin Dede reiterated a Buy rating on Magic Software Enterprises Ltd (MGIC – Research Report) today and set a price target of $10. The company’s shares closed yesterday at $8.89. According to TipRanks.com, Dede is currently ranked

Analyst Explains Why They Downgraded Their Rating on Qualcomm Inc (QCOM)

In a report released today, Vijay Rakesh from Mizuho Securities downgraded Qualcomm Inc (QCOM – Research Report) to Hold, with a price target of $65. The company’s shares closed yesterday at $69.31. Rakesh observed: “We are moving to the sidelines